magnesium(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
magnesium(2+) — decreases HOMA-IR
Evidence strength: very limited.Findingreplicated ×4“Overall, compared with placebo in gestational diabetes, magnesium supplementation was associated with significantly reduced fasting plasma glucose (standard mean difference [SMD] = -0.99; 95% confidence interval [CI] = -1.28 to -0.70; p < .00001), serum insulin (SMD = -0.75; 95% CI = -1.24 to -0.26; p = .003), homeostasis model assessment of insulin resistance (SMD = -0.74; 95% CI = -1.10 to -0.39; p < .0001) and increased quantitative insulin sensitivity check index (SMD = 0.47; 95% CI = 0.12 to 0.82; p = .008).”
Quoted verbatim from Magnesium supplementation for glycemic status in women with gestational diabetes: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Women with gestational diabetes; four randomised controlled trials pooled
Effect -0.74 standardised mean difference, 95% CI -1.1 to -0.39
Magnesium supplementation for glycemic status in women with gestational diabetes: a systematic review and meta-analysis.2022PMID:3490782010.1080/09513590.2021.1988558Permalink
To cite this finding: https://catalystproject.ai/e/01M5N3J3RZRJBWC07R48EZSDRZ